Subramanian Natesan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Subramanian Natesan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Victor Hmingthansanga
Department of Pharmaceutics, Advanced Formulation Laboratory, National Institute of Pharmaceutical Education and Research Kolkata, Kolkata, 700 054, West Bengal, India
2 shared publicationsArab Iram Saba Gaus Mohammed
Department of Pharmaceutics, Advanced Formulation Laboratory, National Institute of Pharmaceutical Education and Research Kolkata, Kolkata, 700 054, West Bengal, India
1 shared publicationBhishal Rajdev
Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, 3GWJ984, Santipur, Parlli Part, Mirza, Guwahati, Assam, 781125, India
1 shared publication- David Paul
Department of Pharmaceutical Analysis National Institute of Pharmaceutical Education and Research Kolkata India
1 shared publication Deepankar Yadav
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Kolkata, West Bengal 700054 India
1 shared publicationJerifa Sonowal
National Institute of Pharmaceutical Education and Research
1 shared publication
Latest Publications
- 2 September 2026
- Published by Springer Nature
- p. 237-258
Thiolated Chitosan: A Versatile Mucoadhesive Polymer for Enhanced Mucosal Drug Delivery
- 2 September 2026
- Published by Springer Nature
- p. 237-258
Thiolated Chitosan: A Versatile Mucoadhesive Polymer for Enhanced Mucosal Drug Delivery
- 26 May 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 699, 127006
Dual drug-loaded nanofibrous scaffolds for targeting dormant breast cancer cells: design, mechanisms, and translational perspectives
- 26 May 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 699, 127006
Dual drug-loaded nanofibrous scaffolds for targeting dormant breast cancer cells: design, mechanisms, and translational perspectives
- 26 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 335 (Pt 2) , 149162
Chitosan coated yeast microcapsules for efficient delivery of cefadroxil for the treatment of inflammatory bowel disease
- 26 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 335 (Pt 2) , 149162
Chitosan coated yeast microcapsules for efficient delivery of cefadroxil for the treatment of inflammatory bowel disease
- 19 February 2025
- Published by Springer Nature
- p. 285-317
Chitosan-Based Formulations for Enhanced Topical, Transdermal, and Ocular Drug Delivery
- 19 February 2025
- Published by Springer Nature
- p. 285-317
Chitosan-Based Formulations for Enhanced Topical, Transdermal, and Ocular Drug Delivery
- Top Cited PapersOpen Access
- 15 December 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2818
Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches
The delivery of drugs via transdermal routes is an attractive approach due to ease of administration, bypassing of the first-pass metabolism, and the large skin surface area. However, a major drawback is an inability to surmount the skin’s stratum corneum (SC) layer. Therefore, techniques reversibly modifying the stratum corneum have been a classical approach. Surmounting the significant barrier properties of the skin in a well-organised, momentary, and harmless approach is still challenging. Chemical permeation enhancers (CPEs) with higher activity are associated with certain side effects restricting their advancement in transdermal drug delivery. Furthermore, complexity in the interaction of CPEs with the skin has led to difficulty in elucidating the mechanism of action. Nevertheless, CPEs-aided transdermal drug delivery will accomplish its full potential due to advancements in analytical techniques, synthetic chemistry, and combinatorial studies. This review focused on techniques such as drug–vehicle interaction, vesicles and their analogues, and novel CPEs such as lipid synthesis inhibitors (LSIs), cell-penetrating peptides (CPPs), and ionic liquids (ILs). In addition, different types of microneedles, including 3D-printed microneedles, have been focused on in this review.
- 15 December 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2818
Top Cited PapersOpen AccessImproved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches
The delivery of drugs via transdermal routes is an attractive approach due to ease of administration, bypassing of the first-pass metabolism, and the large skin surface area. However, a major drawback is an inability to surmount the skin’s stratum corneum (SC) layer. Therefore, techniques reversibly modifying the stratum corneum have been a classical approach. Surmounting the significant barrier properties of the skin in a well-organised, momentary, and harmless approach is still challenging. Chemical permeation enhancers (CPEs) with higher activity are associated with certain side effects restricting their advancement in transdermal drug delivery. Furthermore, complexity in the interaction of CPEs with the skin has led to difficulty in elucidating the mechanism of action. Nevertheless, CPEs-aided transdermal drug delivery will accomplish its full potential due to advancements in analytical techniques, synthetic chemistry, and combinatorial studies. This review focused on techniques such as drug–vehicle interaction, vesicles and their analogues, and novel CPEs such as lipid synthesis inhibitors (LSIs), cell-penetrating peptides (CPPs), and ionic liquids (ILs). In addition, different types of microneedles, including 3D-printed microneedles, have been focused on in this review.